ORDERPAPER
TodayBrowseYour MPCalendar
Order Paper
Data sources & licencesContact us

Contains Parliamentary information licensed under the Open Parliament Licence v3.0. Contains public sector information licensed under the Open Government Licence v3.0. © Parliamentary copyright. © Crown copyright.

BrowsePolicy Papers
POLICYWithdrawnPolicy paper · gov.uk

Government Response to the National Commission's Recommendations on the Regulation of AI in Healthcare.

The government's response published on the 6 October 2026 to provide clarity to stakeholders on how the government intends to take forward the recommendations made by the independent National Commission.

Last fetched 06 Oct 2026 · gov.uk
Documents
Government Response to the National Commission's Recommendations on the Regulation of AI in Healthcare.National Commission into the Regulation of AI in Healthcare - Government Responseapplication/pdf
At a glance
TypePolicy paper
First published05 Oct 2026
Last updated05 Oct 2026
Organisations
Medicines and Healthcare products Regulatory Agency
Topics
Medicines, medical devices
Source
Open on gov.uk
Other from medicines-and-healthcare-products-regulatory-agencySee all →
CONSULT.
Consultation on the regulation of Gene therapy medicinal products
CONSULT.
Draft rare disease therapies regulatory framework
CONSULT.
MHRA consultation on statutory fees (2026)
CONSULT.
Consultation on schools holding Adrenaline Nasal Sprays for anaphylaxis
CONSULT.
Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices
POLICY
UK Position Paper on Microbiome-Based Medicinal Products (MBMPs)
Related policy papers
POLICY
Bovine TB control strategy for England
POLICY
Government response to the recommended bovine TB control strategy for England
POLICY
UK candidacy for International Telecommunication Union Council elections 2026
POLICY
Agenda of the 16th meeting of the Withdrawal Agreement Joint Committee, 10 November 2026